Stelis Biopharma and Pieris, a next generation therapeutic protein R&D firm, have started a long-term collaboration for clinical development and commercialization of multiple novel Anticalin-based protein therapeutics worldwide, primarily ...
Onco Therapies,a wholly owned subsidiary of Strides Arcolab,has received US Food and Drug Administration approval for Cisplatin injection. Cisplatin is a chemotherapy drug used to treat various types of cancers,including ...
Tags: Onco Therapies, Strides Arcolab, Cisplatin injection, chemotherapy drug